Dr Sarvesh soni is currently working as Assistant Director at the Patients and Infrastructure Section of the Health and Medical Research Office. The Patients and Infrastructure Section is responsible for developing policy and managing various grants under several MRFF Initiatives (Medical Research Future Fund). He is primarily involved in conducting policy, program and grant design, implementation and management, and related research and analysis activities. He brings strong analytical, problem solving and research skills and the ability to apply this to complex policy issues and policy development for the Ministers consideration. Moreover, Dr. Soni is an Australian Science Policy Fellow (2021-2022) (selected by the Office of the Chief Scientist) at Australian Department of Health and an Adjunct Principal Research Fellow of RMIT University, Melbourne. He will be bringing a fresh perspectives on the government policy work, and a conduit for bringing scientific expertise into the Australian government policy process. He is an experienced academician/scientist with a demonstrated history of working in the tertiary education industry (RMIT, Monash, CSIRO, and New York University) and conducting highly multidisciplinary translational research. He is skilled in Research and Development (R&D), science policy, disruptive innovations, and technology entrepreneurship.Dr Soni is the founder-director for RMIT Technology and Entrepreneurship Network & Club and helping people with a shared interest in innovations, translation and research commercialisation. Dr. Soni has been trained as a microbiologist and further utilised the underlined principles and methodologies to develop his research profile in nanobiotechnology, microbial diagnostics, and nanotherapeutics, leading to achieving the overarching goal of his research for 'sustainable mitigation of Public Health Risks' by engaging with society, organizations, public and private, communities and individuals. The potential and impact of his research include transformation in the way biosolids are managed in Australia which paves the way for improved and more environmentally sustainable practices globally; novel methods for nanobiomaterials’ synthesis & applications, point of care microbial detection technology for risk mitigation; policy change in regard to the storage and release of recycled water; optimization of the use of sunscreens (and toxic pollutants) in the marine/aquatic environment; and inhaled nano- therapeutics for deadly tuberculosis.